Sabra Health Care REIT (SBRA) Gains from Investment Securities (2013 - 2026)

Sabra Health Care REIT's Gains from Investment Securities history runs 9 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• On a quarterly basis, Gains from Investment Securities fell 30.03% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $7.1 million, a 12.07% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 43.44% from the prior year.
• Gains from Investment Securities retreated to $1.7 million in Q1 2026 per SBRA's latest filing, from $1.9 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $2.4 million in Q1 2025 and bottomed at $367000.0 in Q1 2023.
• The 4-year median for Gains from Investment Securities is $1.7 million (2025), against an average of $1.4 million.
• Across the five-year window, Gains from Investment Securities surged 302.72% in 2024 and sank 30.03% in 2026, its largest moves.
• Year by year, Gains from Investment Securities stood at $1.8 million in 2023, then declined by 4.02% to $1.7 million in 2024, then climbed by 11.99% to $1.9 million in 2025, then slipped by 12.61% to $1.7 million in 2026.
• Per Business Quant, the three latest SBRA Gains from Investment Securities figures stand at $1.7 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025).